Taiwan Biomaterial Co., Ltd. Stock Price

TPEX:6649 Community·NT$2.0b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

6649 Share Price Performance

NT$46.45

9.90 (27.09%)

NT$46.45

9.90 (27.09%)

NT$46.45

Sat, 4 Apr 26

Share Pricen/a

6649 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks

2 Rewards

View Full Analysis

Taiwan Biomaterial Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 1.40
: 61.16%
: 26.74%
: 0%

View Full Analysis

About 6649

Founded: 1921
Employees: 35
CEO: Derek Ma
WebsiteView website: www.twbm.com.tw

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It offers Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan.